Overview
Maynard Nexsen’s Life Sciences Group provides clients with a comprehensive range of legal services throughout the full life cycles of their products and evolving business needs. From initial entity formation and intellectual property protection to drug and medical device approvals, patent litigation and product liability litigation, pharmaceutical, biotechnology and medical device companies routinely call on Maynard Nexsen to help them navigate the changing landscapes of these rapidly evolving fields.
Maynard Nexsen attorneys have experience advising large and small life sciences clients involved in a wide range of areas, including biologics, biosimilars, pharmaceuticals, medical devices, diagnostic technologies, and drug delivery systems. Our multidisciplinary life sciences team includes attorneys with expertise in key areas of law that impact life sciences companies, including corporate formation, intellectual property, regulatory matters including approvals, healthcare, litigation, products liability, and class actions.
Intellectual property is at the heart of the life sciences industry. We offer clients a full range of intellectual property legal services and advice for their products, from transactional to litigation matters. Our intellectual property lawyers have extensive experience in patent and trademark prosecution, licensing, and portfolio management. Our team also has extensive experience in patent litigation, including Hatch-Waxman litigation, and appeals to the Court of Appeals to the Federal Circuit.
When it comes to the life sciences industry, two things are clear: The landscape of healthcare is rapidly changing. And to remain successful, companies must continue to seek the highest standards of innovation while managing all the evolving issues that come with today’s new operating environment – from increasing regulatory scrutiny to heightened competition from generic providers.
Maynard Nexsen attorneys understand the trends reshaping the life sciences industry and have the experience and backgrounds necessary to handle the gamut of concerns facing pharmaceutical, biotechnology, medical device, and healthcare service companies.
We help clients stay at the forefront of advancements and breakthroughs in medical care by employing legal strategies that support virtually every phase of a company’s development and product lifecycle.
Clients in the life sciences industry turn to us for our broad-based knowledge in:
- Intellectual property licensing, protection, and enforcement, including issues with patents, copyrights, and trademarks
- Mergers and acquisitions
- Structuring and negotiating corporate alliances, partnerships, and collaborations
- Evaluations of capital projects
- Public and private equity and debt financings
- General securities and corporate governance/compliance matters
- Research and development financings
- Technology licensing and contracts
- Compliance with marketing programs, research and development initiatives, regulations and regulatory entities, and tax law
- Litigation
Regulatory Experience
We help clients understand the laws and regulations applying to industries working in the chemistry, biotech and pharmaceutical areas. We assist in securing the required permits or licenses from local, state and federal agencies. We also assist clients with government inspections and government representation.
The federal agencies we have experience working with include:
- Food and Drug Administration
- Department of Transportation
- Environmental Protection Agency
- Bureau of Alcohol Tobacco and Firearms
- Occupational Safety and Health Administration
- Department of Agriculture
- Drug Enforcement Administration
Media
Insights
Videos/Podcasts
Health care attorney Matthew Roberts discusses the significant impact of ESG, or Environmental, Social, and Governance, for life sciences companies.
Matthew Roberts examines the significant and sometimes positive changes occurring in clinical research processes in the life sciences industry caused by the COVID-19 pandemic.
Nexsen Pruet's newest webinar series is focusing on Life Sciences companies in the Carolinas. These webinars will focus on various legal and regulatory issues that Life Sciences companies deal with on a daily basis. They are also designed to provide updates and strategies on how to deal with these issues.
The future of the life sciences industry is bright in South Carolina. Nexsen Pruet's health care practice group leader Matthew Roberts highlights the economic impact of one of the State's fastest growing industry sectors.
Nexsen Pruet's newest webinar series is focusing on Life Sciences companies in the Carolinas. These webinars will focus on various legal and regulatory issues that Life Sciences companies deal with on a daily basis. They are also designed to provide updates and strategies on how to deal with these issues.
Nexsen Pruet's newest webinar series is focusing on Life Sciences companies in the Carolinas. These webinars will focus on various legal and regulatory issues that Life Sciences companies deal with on a daily basis. They are also designed to provide updates and strategies on how to deal with these issues.
Podcasts
- 10.04.2022 | Taking the Pulse: A Health Care & Life Sciences Podcast - Episode 115: Dr. Michael Havig, CEO, HealthMe
Matthew and Amanda welcome Dr. Michael Havig, HealthMe founder and CEO, to episode 115. Michael is an orthopedic surgeon and sports medicine specialist who created HealthMe to help patients find the best health care and save money while also helping providers grow revenues and simplify pricing. Tune in to hear Dr. Havig discuss how his engagement platform is a leader in the price transparency trend and his insights on the No Surprises Act!
- 09.20.2022 | Taking the Pulse: A Health Care & Life Sciences Podcast - Episode 113: with Ryan Loehr, Managing Director, AMB Wealth
On episode 113, Amanda Loveday and Darra James Colman sit down with the Managing Director of AMB Wealth, Ryan Loehr. They discuss his experience advising private equity firms and public companies across the health care and life sciences industries, the investment banking opportunities for health care and life sciences businesses, and much more. Tune in now!
StartUp Health is uniting entrepreneurs and investing in transformative innovation in the health care sector. On this episode, we're joined by their Chief Content Officer, Logan Plaster, who tells us about his work, StartUp Health's unique practices, and how the health care industry is evolving. Tune in!
On this episode we're joined by Will Britt, Chief Counsel for Public Health for the South Carolina Department of Health and Environmental Control. He offers up his perspective on how people's perception of public health has changed in the wake of a pandemic, what exactly his role is at the agency, and more.
- 08.18.2022 | Taking the Pulse: A Health Care and Life Sciences Podcast - Episode 110: Meg Kinnard and Vickie Eslinger
On this episode we're joined by Meg Kinnard, a journalist with the Associated Press, and Vickie Eslinger, Nexsen Pruet attorney, to discuss their health care experiences.
Matthew and Heather welcome back Sam Konduros to discuss his new role as President and CEO of KOR Medical. KOR Medical is a recently launched health innovation company that plans to set the standard in the arena of personalized, clinical cannabis to benefit patients suffering from diseases like epilepsy and cancer and to help alleviate the nationwide opioid crisis. Tune in now and learn more about this exciting South Carolina based company!